Dr. Farnaz Zahedi Avval
My Social Links

Dr. Farnaz Zahedi Avval

Lab Assisstant
Karolinska Institute, Sweden

Highest Degree
Ph.D. in Clinical Biochemistry from Karolinska Institutet, Sweden

Share this Profile

Area of Interest:

Chemistry
100%
Clinical Biochemistry
62%
Biophysical Chemistry
90%
Chemical Compound
75%
Microbiology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Sisakht, M., B. Mashkani, A. Bazi, H. Ostadi and M. Zare et al., 2017. Bee venom induces apoptosis and suppresses matrix metaloprotease-2 expression in human glioblastoma cells. Rev. Bras. Farmacogn., 27: 324-328.
    CrossRef  |  Direct Link  |  
  2. Avval, F.Z., M. Khadem-Rezaiyan, Z. Agheltar and M. Youssefi, 2017. Status of serum magnesium levels in human T-cell lymphotropic virus Type 1 infected patients: A pilot study. Int. J. Med. Sci. Public Health, 6: 816-819.
  3. Alizadeh, K., M. Tabari, F.Z. Avval, L. Mashhadi and A. Izanloo, 2017. A comparative study of homocysteine levels in patients undergoing coronary bypass. Chirurgia, 30: 79-83.
  4. Rezaiyan, M.K., F.Z. Avval, Z. Agheltar and M. Youssefi, 2016. Magnesium level in patients with adult T-Cell leukemia: A case report. Arch. Clin. Infect. Dis., 11: 1-2.
  5. Rezaiyan, M.K., F.Z. Avval, K. Ghazvini and M. Youssefi, 2016. Medical and dentistry students’ viewpoints about physician-scientists as their basic science educators. J. Med. Educ. Dev., 9: 122-129.
    Direct Link  |  
  6. Pouya, V.T., S.I. Hashemy, A. Shoeibi, A.N. Tirkani and S. Tavallaie et al., 2016. Serum pro-oxidant-antioxidant balance, advanced oxidized protein products (AOPP) and protein carbonyl in patients with stroke. Razavi Int. J. Med., Vol. 4. 10.17795/rijm38203.
    CrossRef  |  Direct Link  |  
  7. Shomali, S., F.Z. Avval, R. Boostani, L. Jarahi and M. Youssefi, 2015. Serum total antioxidant capacity status of HTLV-1 infected patients. Acta Virol., 59: 199-203.
    PubMed  |  
  8. Panah, S.D.E., N.K. Tousi, L. Rahimi, G. Sabouri, A. Mirsalehi and F.Z. Avval, 2015. Comparison of two methods for measurement of HbA1c in two university hospitals of Mashhad. J. Patient Saf. Qual. Improv., 3: 262-265.
    CrossRef  |  Direct Link  |  
  9. Nadri, M., M. Soukhtanloo, A.H. Jafarian, M. Alamdari, M. Sisakhti, T. Kianoush and F.Z. Avval, 2015. Production and characterization of monoclonal antibodies against the dimerization domain of human HER2. Avicenna J. Med. Biochem., Vol. 3. 10.17795/ajmb-29918.
    CrossRef  |  
  10. Khadem-Rezaiyan, M., F.Z. Avval and M. Youssefi, 2015. Nursing students viewpoints about basic sciences education. Int. J. Educ. Res., 3: 109-116.
    Direct Link  |  
  11. Avval, F.Z., S. Shomali, M. Nadri, R. Boostani, L. Jarahi and M. Youssefi, 2015. Status of soluble ST2 levels in serum of HTLV-1 infected individuals. Acta Microbiol. Immunol. Hung., 62: 137-145.
    CrossRef  |  Direct Link  |  
  12. Avval, F.Z., K. Ghazvini and M. Youssefi, 2014. Ethical and professional issues training for students and staff of laboratory medicine. Future Med. Educ. J., 4: 13-16.
    CrossRef  |  Direct Link  |  
  13. Avval, F.Z., L. Jarahi, K. Ghazvini and M. Youssefi, 2013. Distribution of handouts in an undergraduate class to create more effective educational environment. Int. J. Educ. Res., 12: 1-6.
  14. Avval, F.Z., F. Pourhaji, M. Youssefi, F. Pourhaji and S.I. Hashemy, 2013. A study of PhD students’ perspectives concerning pedagogic training in doctoral program. Future Med. Educ. J., 3: 29-32.
    CrossRef  |  Direct Link  |  
  15. Hudemann, C., M.E. Lonn, J.R. Godoy, F.Z. Avval, F. Capani, A. Holmgren and C.H. Lillig, 2009. Identification, expression pattern, and characterization of mouse glutaredoxin 2 isoforms. Antioxidants Redox Signal., 11: 1-14.
    CrossRef  |  Direct Link  |  
  16. Avval, F.Z., C. Berndt, A. Pramanik and A. Holmgren, 2009. Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd). Biochem. Biophys. Res. Commun., 379: 775-779.
    CrossRef  |  Direct Link  |  
  17. Avval, F.Z. and A. Holmgren, 2009. Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide reductase. J. Biol. Chem., 284: 8233-8240.
    CrossRef  |  Direct Link  |  
  18. Hashemy, S.I., J.S. Ungerstedt, F.Z. Avval and A. Holmgren, 2006. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. J. Biol. Chem., 281: 10691-10697.
    CrossRef  |  Direct Link  |